DaehanPharmaceutical operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares DaehanPharmaceutical with three other
companies in this sector in KOREA (SOUTH) :
Kolon Life Science Incorporation
sales of 148.54 billion Korean Won [US$127.75 million]
of which 98%
(176.50 billion Korean Won [US$151.79 million]
of which 95%
was Medicine), and
Kyongbo Pharmaceutical Co Ltd
(191.71 billion Korean Won [US$164.87 million]
of which 37%
was General API).
DaehanPharmaceutical reported sales of 168.76 billion Korean Won (US$145.14 million)
December of 2019.
increase of 6.3%
versus 2018, when the company's sales were 158.72 billion Korean Won .
Sales at DaehanPharmaceutical have increased during each of the previous five years
(and since 2014, sales have increased a total of 51%).